185 related articles for article (PubMed ID: 8813126)
1. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
Fan H; Villegas C; Huang A; Wright JA
Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
[TBL] [Abstract][Full Text] [Related]
2. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
Burton TR; Kashour T; Wright JA; Amara FM
Int J Oncol; 2003 Jan; 22(1):21-31. PubMed ID: 12469181
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
[TBL] [Abstract][Full Text] [Related]
4. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
Amara FM; Hurta RA; Huang A; Wright JA
Cancer Res; 1995 Oct; 55(20):4503-6. PubMed ID: 7553616
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
Cao MY; Lee Y; Feng NP; Xiong K; Jin H; Wang M; Vassilakos A; Viau S; Wright JA; Young AH
Clin Cancer Res; 2003 Oct; 9(12):4553-61. PubMed ID: 14555530
[TBL] [Abstract][Full Text] [Related]
6. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
Fan H; Villegas C; Huang A; Wright JA
Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
[TBL] [Abstract][Full Text] [Related]
7. GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.
Lee Y; Vassilakos A; Feng N; Jin H; Wang M; Xiong K; Wright J; Young A
Int J Oncol; 2006 Feb; 28(2):469-78. PubMed ID: 16391803
[TBL] [Abstract][Full Text] [Related]
8. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
Amara FM; Smith GM; Kuschak TI; Takeuchi TL; Wright JA
Biochem Biophys Res Commun; 1996 Nov; 228(2):347-51. PubMed ID: 8920917
[TBL] [Abstract][Full Text] [Related]
9. GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.
Lee Y; Vassilakos A; Feng N; Lam V; Xie H; Wang M; Jin H; Xiong K; Liu C; Wright J; Young A
Cancer Res; 2003 Jun; 63(11):2802-11. PubMed ID: 12782585
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Hurta RA; Wright JA
J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.
Wang E; Ma WJ; Aghajanian C; Spriggs DR
Cancer Res; 1997 Dec; 57(23):5426-33. PubMed ID: 9393771
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
[TBL] [Abstract][Full Text] [Related]
13. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
14. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
[TBL] [Abstract][Full Text] [Related]
15. [Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice].
Wang BH; Qian W; Gao YJ; Wang HF; Hou XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):266-71. PubMed ID: 16677508
[TBL] [Abstract][Full Text] [Related]
16. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.
Fan H; Huang A; Villegas C; Wright JA
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13181-6. PubMed ID: 9371820
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Florenes VA; Fodstad O; Scanlon KJ
Cancer Res; 1994 Feb; 54(4):900-2. PubMed ID: 8313379
[TBL] [Abstract][Full Text] [Related]
18. Norepinephrine specifically stimulates ribonucleotide reductase subunit R2 gene expression in proliferating brown adipocytes: mediation via a cAMP/PKA pathway involving Src and Erk1/2 kinases.
Fredriksson JM; Nedergaard J
Exp Cell Res; 2002 Apr; 274(2):207-15. PubMed ID: 11900481
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms.
Wang XY; McCubrey JA
Cell Growth Differ; 1996 Apr; 7(4):487-500. PubMed ID: 9052990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
